Volume 146, Issue 4, Pages (August 2011)

Slides:



Advertisements
Similar presentations
Volume 12, Issue 5, Pages (November 2007)
Advertisements

Volume 12, Issue 5, Pages (November 2007)
Kenneth G. Geles, Wenyan Zhong, Siobhan K
Volume 5, Issue 2, Pages (August 2009)
Chandra M.V. Goparaju, PhD  Journal of Thoracic Oncology 
Restoration of Corneal Transparency by Mesenchymal Stem Cells
Volume 2, Issue 4, Pages (April 2008)
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Volume 3, Issue 1, Pages (July 2008)
Volume 14, Issue 5, Pages (May 2014)
Volume 2, Issue 6, Pages (June 2014)
Volume 8, Issue 2, Pages (February 2011)
Volume 3, Issue 4, Pages (October 2008)
Volume 47, Issue 6, Pages e4 (December 2017)
Volume 20, Issue 12, Pages (September 2017)
Volume 9, Issue 5, Pages (November 2017)
Volume 2, Issue 6, Pages (June 2014)
Volume 28, Issue 2, Pages (August 2015)
Volume 25, Issue 6, Pages e4 (November 2018)
Volume 133, Issue 4, Pages (May 2008)
Volume 13, Issue 5, Pages (May 2008)
Fuqing Wu, David J. Menn, Xiao Wang  Chemistry & Biology 
Christine V. Ichim, Džana D
Bone Marrow–Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality  Elizabeth O. Stenger, Raghavan Chinnadurai,
Volume 138, Issue 4, Pages (August 2009)
Volume 6, Issue 1, Pages (January 2016)
Volume 42, Issue 6, Pages (June 2015)
Lea Goentoro, Marc W. Kirschner  Molecular Cell 
Nachiket Shembekar, Hongxing Hu, David Eustace, Christoph A. Merten 
Volume 117, Issue 7, Pages (June 2004)
Volume 28, Issue 3, Pages (March 2008)
Michal Levin, Tamar Hashimshony, Florian Wagner, Itai Yanai 
High Expression of CD200 and CD200R1 Distinguishes Stem and Progenitor Cell Populations within Mammary Repopulating Units  Gat Rauner, Tania Kudinov,
Volume 10, Issue 5, Pages (May 2018)
Lineage Identity and Location within the Dermis Determine the Function of Papillary and Reticular Fibroblasts in Human Skin  Ana Korosec, Sophie Frech,
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Derivation and FACS-Mediated Purification of PAX3+/PAX7+ Skeletal Muscle Precursors from Human Pluripotent Stem Cells  Bianca Borchin, Joseph Chen, Tiziano.
Volume 36, Issue 2, Pages (February 2012)
Side Population Keratinocytes Resembling Bone Marrow Side Population Stem Cells Are Distinct From Label-Retaining Keratinocyte Stem Cells  Atsushi Terunuma,
Volume 25, Issue 2, Pages (August 2006)
Volume 2, Issue 1, Pages (January 2014)
Volume 9, Issue 3, Pages (September 2017)
Volume 9, Issue 1, Pages (July 2011)
Histone Modifications Associated with Somatic Hypermutation
Mesenchymal Stem Cell Features of Ewing Tumors
Identification of White Adipocyte Progenitor Cells In Vivo
Volume 10, Issue 4, Pages (April 2018)
Volume 15, Issue 1, Pages (January 2009)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Targeting SOX17 in Human Embryonic Stem Cells Creates Unique Strategies for Isolating and Analyzing Developing Endoderm  Pei Wang, Ryan T. Rodriguez,
Volume 16, Issue 1, Pages (January 2015)
Haploinsufficiency at the Nkx3.1 locus
Volume 3, Issue 4, Pages (October 2008)
Volume 138, Issue 4, Pages (August 2009)
Volume 126, Issue 6, Pages (September 2006)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 17, Issue 4, Pages (October 2015)
Volume 16, Issue 2, Pages (February 2002)
Volume 10, Issue 3, Pages (March 2018)
Volume 2, Issue 3, Pages (March 2008)
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells by Ana Camelo, Guglielmo Rosignoli, Yoichiro.
Cellular Heterogeneity in the Mouse Esophagus Implicates the Presence of a Nonquiescent Epithelial Stem Cell Population  Aaron D. DeWard, Julie Cramer,
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
Volume 22, Issue 3, Pages (March 2005)
An Mll-Dependent Hox Program Drives Hematopoietic Progenitor Expansion
Enhancer Control of Transcriptional Bursting
Volume 10, Issue 7, Pages (February 2015)
Volume 26, Issue 13, Pages e5 (March 2019)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Volume 21, Issue 6, Pages (June 2012)
Presentation transcript:

Volume 146, Issue 4, Pages 633-644 (August 2011) Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells  Piyush B. Gupta, Christine M. Fillmore, Guozhi Jiang, Sagi D. Shapira, Kai Tao, Charlotte Kuperwasser, Eric S. Lander  Cell  Volume 146, Issue 4, Pages 633-644 (August 2011) DOI: 10.1016/j.cell.2011.07.026 Copyright © 2011 Elsevier Inc. Terms and Conditions

Cell 2011 146, 633-644DOI: (10.1016/j.cell.2011.07.026) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Isolation of Stem-like, Luminal, and Basal Cell-Differentiation States in Human Breast Cancer Lines (A) Flow cytometry gating strategy for isolating CD44loCD24hiEpCAMhi, CD44hiCD24negEpCAMneg, and CD44hiCD24negEpCAMlo subpopulations from SUM149 and SUM159 human breast cancer lines. (B) Morphology of SUM149 and SUM159 colonies cultured immediately after cell sorting. Representative phase-contrast bright-field images of colonies from sorted CD44lo/CD24hi/EpCAMhi cells comprised of epithelial islands exhibiting cobblestone morphology and tight cell-cell junctions, consistent with a luminal cell phenotype. CD44hi/CD24neg/EpCAMneg cells from colonies exhibiting spindloid features reminiscent of basal cell morphology. CD44hi/CD24neg/EpCAMlo colonies are able to exhibit mixed morphologies representing luminal and basal phenotypes, consistent with differentiation of stem-like cells. (C) Messenger RNA (mRNA) was extracted from the sorted luminal, basal, and stem-like subpopulations and Affymetrix gene chips were then hybridized to pooled mRNA samples (between three to five independent sorts were pooled per marker profile combination and cell line). The heat map displays differentially expressed genes that can distinguish between the three cell states. Genes having multiple instances correspond to distinct probe sets. (D) Schematic depicting the results of GSEA performed to determine whether genes previously published to be associated with luminal, mesenchymal or stem cell differentiation are upregulated in sorted CD44loCD24hiEpCAMhi (luminal), CD44hiCD24negEpCAMneg (basal), and CD44hiCD24negEpCAMlo (stem-like) subpopulations. The ten gene lists analyzed are described in Table S1 and include basal, CD44vsCD24up, TGFβ, stem, differentiated, sphere versus differentiated down, luminal, luminal A, sphere versus differentiated up, and mesenchymal. The gene lists are shown superimposed upon the cellular subpopulation(s) in which they were enriched, together with an associated p value calculated by permutation testing. Gene lists with corresponding references are described in Table S1. (E) Quantitative RT-PCR analysis of Vimentin, N-cadherin, E-cadherin, and Zeb1 expression in SUM149 or SUM159 sorted cell populations relative to expression in the parental (unsorted) cell line. Data are represented as the average ΔΔCt ± standard error of the mean (SEM). n = 3. See also Table S1. Cell 2011 146, 633-644DOI: (10.1016/j.cell.2011.07.026) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Determination of Breast Cancer Cell-State Transition Probabilities from Population Cell-State Proportions (A) Schematic of experimental procedure used to determine cell-state transition dynamics. (B) Proportions of cell-states in parental SUM159shCntrl and SUM149shCntrl breast cancer lines. (C) Cellular subpopulations in stem-like (SL), basal, or luminal states were isolated by FACS with antibodies directed against the CD44, CD24, and EpCAM cell-surface antigens. Bar charts show the proportion of cells in each cell-differentiation state as assessed by FACS after in vitro culture for 6 days. (D) Lineage hierarchies for the SUM159shCntrl and SUM149shCntrl lines were calculated from the data in (C). The corresponding cell-state transition probabilities for each cell line are shown. Solid arrows denote transition probabilities greater than 0.1. Dashed arrows denote transition probabilities between 0.01 and 0.1. See also Figure S1. Cell 2011 146, 633-644DOI: (10.1016/j.cell.2011.07.026) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Prediction of Cell-State Dynamics with the Stochastic Cell-State Transition Model The transition probabilities determined for the SUM159 line were used to compute the expected cell-state proportions over time for isolated subpopulations of stem-like, basal, or luminal cells. For all three isolated subpopulations, an eventual return to equilibrium cell-state proportions is predicted. The model predicts a transient increase in the proportion of SUM159 luminal cells one day after isolation of a stem-like subpopulation (red arrow). Cell 2011 146, 633-644DOI: (10.1016/j.cell.2011.07.026) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Analysis of Chemical Treatment Sensitivities by Monte Carlo Simulation with the Stochastic Cell-State Transition Model (A) Cell-state proportions after a 6 day treatment with either paclitaxel or 5-FU are shown for SUM159 and SUM149 populations. (B) A schematic showing how differential chemical treatment sensitivities can be incorporated into the Markov stochastic model. The matrix of transition probabilities is premultiplied by a differential viability matrix. The diagonal entries of this matrix, (vB, vS, and vL), encode the survival probabilities of basal, stem-like and luminal cells in the presence of chemical treatment. These entries are normalized to sum to 1. Monte Carlo simulation is performed by random sampling of differential viability vectors. (C) The results of Monte Carlo simulation, shown as ternary density contour plots in which coloration represents the normalized difference (see the Experimental Procedures for the metric used) between experimentally observed and predicted cell-state proportions following chemical treatment. Ten thousand random points within the triangle simplex were sampled, each representing a distinct choice of differential viability vector, (vB, vS, vL), with entries ranging from zero (sensitive) to one (resistant). Cell 2011 146, 633-644DOI: (10.1016/j.cell.2011.07.026) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 Two Distinct Models of Cancer Cell Populations In the existing paradigm (model I), CSCs give rise to non-CSCs but not vice versa, resulting in a hierarchical cell-lineage structure reflective of normal tissue biology. We propose an alternative scenario (model II) in which there is bidirectional interconversion between CSC and non-CSC states. The rates of transition between cell states, which vary across distinct cancer cell populations, can be computed with the Markov modeling approach described in the main text and Experimental Procedures. Cell 2011 146, 633-644DOI: (10.1016/j.cell.2011.07.026) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure S1 Related to Figure 2 In vitro proliferation curves of parental or purified subpopulations of SUM159 or SUM149 breast cancer cells. Population doublings (PDs) are shown. Cell 2011 146, 633-644DOI: (10.1016/j.cell.2011.07.026) Copyright © 2011 Elsevier Inc. Terms and Conditions